Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novo nordisk a::S crawled time : 15:00 save search
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.42%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.84%
H: 0.86%
C: -0.62%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.58%
H: 0.99%
C: 0.97%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.21%
H: 0.11%
C: -3.05%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.18%
H: 0.84%
C: 0.6%
report reach therapeutics market
Resolutions from the Annual General Meeting of Novo Nordisk A/S
Published: 2024-03-21 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.04%
H: 1.6%
C: 0.64%
meeting
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-02-08 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.51%
H: 0.49%
C: 0.29%
Novo Nordisk A/S - share repurchase programme
Published: 2023-11-20 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.11%
H: 2.21%
C: 2.06%
repurchase
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-07 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.32%
H: 1.23%
C: 0.92%
Novo Nordisk A/S - share repurchase programme
Published: 2023-09-25 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.44%
H: 0.33%
C: 0.25%
repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2023-08-21 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.21%
H: 0.55%
C: 0.28%
repurchase
Novo Nordisk takes actions to help protect US patients from unlawful sales of non-FDA approved medicines claiming to contain semaglutide
Published: 2023-06-20 (Crawled : 15:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.0%
H: 1.9%
C: 1.25%
sales approved
Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial
Published: 2023-05-22 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.04%
H: 0.86%
C: 0.02%
obesity trial
Nonalcoholic Steatohepatitis Market Evolving at a Rapid Pace, Predicts DelveInsight | Key Companies Active in the Domain - Madrigal, Intercept, AstraZeneca, Gilead, Pfizer, Alnylam, Eli Lilly and Company, Novo Nordisk
Published: 2023-04-24 (Crawled : 15:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.02%
H: 0.31%
C: -0.24%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.0%
H: 0.47%
C: -0.49%
VKTX | $63.38 -2.0% -2.04% 3M
|
Health Technology
|
| O: 0.99%
H: 2.87%
C: -0.42%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
MTCR | $0.5814 -5.14% 84K
|
Health Technology
|
| O: 0.63%
H: 1.35%
C: 0.45%
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
|
| O: -0.33%
H: 1.28%
C: 1.12%
LPCN | $5.33 -2.02% -2.06% 11K
|
Health Technology
|
| O: -2.31%
H: 7.94%
C: 1.01%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -3.64%
HEPA | News | $2.11 -0.09% -0.09% 73K
|
Health Technology
|
| O: 0.04%
H: 1.48%
C: -3.31%
GALT | $3.37 -0.3% -0.3% 210K
|
Health Technology
|
| O: 0.0%
H: 1.04%
C: -4.17%
CWBR | $0.9003 -11.88% 360
|
Health Technology
|
| O: -3.68%
H: 1.1%
C: -1.63%
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: -0.69%
H: 0.87%
C: -4.0%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.08%
H: 0.18%
C: -2.07%
ETNB | $9.08 2.25% 2.2% 1M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: -5.88%
companies active rapid market
Parkinson's Disease Clinical Trial Pipeline Space Brims With Novel Emerging Therapies with Over 120 Key Companies Working in the Domain | DelveInsight
Published: 2023-04-19 (Crawled : 15:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -3.51%
H: 1.28%
C: 0.74%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.17%
H: 0.2%
C: -0.02%
VTGN | $4.77 1.49% 1.47% 150K
|
Health Technology
|
| O: 0.0%
H: 2.59%
C: -0.49%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: -1.11%
H: 1.31%
C: 0.56%
BIVI | $0.4874 -0.21% -0.21% 490K
|
Health Technology
|
| O: -0.24%
H: 4.29%
C: 0.49%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.39%
H: 0.4%
C: -0.14%
APTX | $0.061 21.31% 7.8M
|
Health Services
|
| O: 2.05%
H: 13.81%
C: 11.81%
AVXL | News | $3.8 0.0% 2.1M
|
Health Technology
|
| O: -0.74%
H: 2.73%
C: 1.61%
disease companies parkinson's pipeline space trial
Novo Nordisk A/S - share repurchase programme
Published: 2023-04-17 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.45%
H: 0.38%
C: 0.01%
repurchase
Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor Agonist
Published: 2023-02-23 (Crawled : 15:00) - globenewswire.com
BIOR | $0.6156 2.69% 2.62% 100K
|
Health Care and Social Assistan...
|
| O: -1.03%
H: 5.57%
C: 5.57%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.63%
H: 0.48%
C: -0.17%
agonist therapeutics
Novo Nordisk A/S - share repurchase programme
Published: 2023-02-16 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.9%
H: 0.3%
C: -0.72%
repurchase
Novo Nordisk A/S – Share repurchase programme
Published: 2023-01-16 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
repurchase
Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2022-11-03 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.41%
H: 2.85%
C: 2.01%
Novo Nordisk A/S – Share repurchase programme
Published: 2022-10-10 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.01%
H: 0.09%
C: -0.21%
repurchase
Novo Nordisk's sales increased by 25% in Danish kroner and by 16% at constant exchange rates to DKK 83.3 billion in the first six months of 2022
Published: 2022-08-03 (Crawled : 15:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -2.42%
H: 0.15%
C: -12.28%
sales six
Global Therapeutic Proteins Market Report 2022-2031 Featuring Major Players - Abbott Laboratories; Amgen Inc.; Baxter International Inc.; Eli Lilly and Company; F.Hoffmann-La Roche
Published: 2022-06-20 (Crawled : 15:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
report roche international market
Global Buccal Drug Delivery System Market Size Will Reach Over USD 6.31 Billion By 2030, at CAGR of 9.6%: Polaris Market Research
Published: 2022-05-09 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.83%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.69%
H: 0.28%
C: -1.1%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -3.0%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.45%
H: 0.21%
C: -0.67%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
drug research system market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.